YY/T 1160-2021 Active Industry standards-Medicine

YY/T 1160-2021 Carcinoembryonic antigen testing kit

YY/T 1160-2021 Carcinoembryonic antigen testing kit

Publish Date: 2021-12-06 Implement Date: 2022-12-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Basic Information

Standard Code: YY/T 1160-2021
Standard Type: Industry standards
Standard Status: Active
is_force_gb: no
CCS Name: Medical laboratory equipment
ICS Name: Laboratory medicine
Publish Date: 2021-12-06
Implement Date: 2022-12-01
Pages: 12 pages

Scope

This document specifies the classification, requirements, testing methods, labels and user manuals, packaging, transportation, and storage of cancer embryonic antigen (CEA) assay kits.
This document applies to assay kits that quantitatively determine CEA based on the principle of double antibody sandwich assay, including luminescent immunoassay kits and enzyme-linked immunosorbent assay kits using labeling methods such as chemiluminescence, electrochemiluminescence, and fluorescence.
This document does not apply to various radioimmunoassay or immunoradiometry kits labeled with radioisotopes such as 125I for CEA.

Development Information

Word Count: 16 Thousand words Pages: 12 pages

Replace the following standards

YY/T 1160-2009

Referenced Standards

Related Standards

Contact Us